Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram

A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of perinatology 2007-02, Vol.27 (2), p.120-122
Hauptverfasser:	Potts, A L, Young, K L, Carter, B S, Shenai, J P
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Antidepressants Babies Blood platelets Breast milk Breastfeeding & lactation Case studies Citalopram Citalopram - adverse effects Citalopram - therapeutic use Diagnosis Diseases Dosage and administration Drug therapy Enterocolitis Enterocolitis, Necrotizing - chemically induced Enterocolitis, Neonatal necrotizing Enterocolitis, Pseudomembranous Female Gastrointestinal diseases Hospitals Humans Infant, Newborn Inhibitors Intensive care Intrauterine exposure Medical examination Milk, Human - drug effects Necrosis Necrotizing enterocolitis Newborn babies Nitric oxide Patient outcomes Pediatrics Pregnancy Pregnancy Complications - drug therapy Pregnant women Prenatal Exposure Delayed Effects - chemically induced Pulmonary hypertension Risk factors Serotonin Serotonin uptake inhibitors Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - therapeutic use Smooth muscle Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.
ISSN:	0743-8346 1476-5543
DOI:	10.1038/sj.jp.7211640